Target intelligence / Profile preview

Sialic acid-containing host cell receptor

Molecular classification
Other (glycoconjugate/glycan; not a classic protein receptor family), Receptor (broadly, as a viral attachment factor or physiological ligand), Glycoprotein (when referring to cell surface proteins), Glycolipid (when referring to sialylated gangliosides)
01

Overview

Sialic acid-containing host cell receptors are not a single protein but refer to the diverse array of **glycoproteins and glycolipids on mammalian cell surfaces that terminate in sialic acid residues**. These sialylated structures serve as crucial **attachment sites for many viruses, including all influenza viruses**, which use different sialic acid linkage types (e.g., α-2,3 and α-2,6) to determine host and tissue specificity[2][3][7]. The sialylation pattern also mediates **cellular communication, immune modulation**, and protection against complement attack[5][1][4]. While this class of molecules is essential for normal cell function, pathogens commonly exploit these glycans as **points of entry** or to evade the immune system. There is no single, canonical gene or protein for this target; instead, it is operationally defined as a critical *cell surface determinant* for pathogen-host interaction and as a modulator of cellular and immune processes—not as a unique molecular entity[2][7].

Other names
Sialylated glycan receptorSialylated glycoprotein receptorSialoglycan receptorSialic acid-binding receptorSialic acid-containing glycoprotein receptor
02

Mechanism of action

Blockade of viral binding/attachment (via competitive inhibition at the sialic acid binding site); Enzyme inhibition (neuraminidase inhibitors prevent viral release by blocking cleavage of sialic acid); Potential direct masking of sialylated epitopes (to modulate immune response or virus binding)

03

Biological functions

Viral attachment and entry (especially influenza and some coronaviruses)Cellular communicationImmune modulation (e.g., immune evasion, complement regulation)Signal transduction (indirectly, through interaction with viral or endogenous lectins)Cell-cell interaction/adherence
04

Disease associations

Infection (especially as entry receptors for influenza, coronaviruses, parainfluenza, and others)Inflammation and autoimmune disease (especially ganglioside-associated immune phenomena and complement regulation)Cancer (tumor cell sialylation is associated with metastasis and immune evasion)
05

Safety considerations

Ubiquitous expression: Sialic acid residues are present on most mammalian cells—broad targeting may risk toxicity or unintended immune effectsModulation may interfere with normal immune regulation (complement, Siglec signaling)Potential for autoimmune phenomena when manipulating sialic acid biology
06

Interacting drugs

Neuraminidase inhibitors (oseltamivir, zanamivir) act on viral enzymes targeting these binding sites, not the host receptor directly

2 more in the full profile.

07

Biomarkers

Cell-surface sialylation patterns (can stratify susceptibility to certain viral infections, e.g., α-2,3 vs α-2,6 linkages for zoonotic/pandemic influenza risk)Specific sialylation (or loss of sialylation) as a biomarker for metastatic cancer or inflammation

Beyond the preview

Go deeper on Sialic acid-containing host cell receptor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sialic acid-containing host cell receptor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call